Literature DB >> 19559045

Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes.

Heike Tost1, Tajvar Alam, Andreas Meyer-Lindenberg.   

Abstract

Schizophrenia is a chronic, severe, and disabling brain disorder arising from the adverse interaction of predisposing risk genes and environmental factors. The psychopathology is characterized by a wide array of disturbing cognitive, emotional, and behavioral symptoms that interfere with the individual's capacity to function in society. Contemporary pathophysiological models assume that psychotic symptoms are triggered by a dysregulation of dopaminergic activity in the brain, a theory that is tightly linked to the serendipitous discovery of the first effective antipsychotic agents in the early 1950s. In recent years, the availability of modern neuroimaging techniques has significantly expanded our understanding of the key mediator circuits that bridge the gap between genetic susceptibility and clinical phenotype. This paper discusses the pathophysiological concepts, molecular mechanisms and neuroimaging evidence that link psychosis to disturbances in dopamine neurotransmission. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559045      PMCID: PMC2838993          DOI: 10.1016/j.neubiorev.2009.06.005

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  133 in total

Review 1.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

Review 2.  Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.

Authors:  Jin-Bo Fan; Chang-Shun Zhang; Niu-Fan Gu; Xing-Wang Li; Wei-Wei Sun; Hong-Yan Wang; Guo-Yin Feng; David St Clair; Lin He
Journal:  Biol Psychiatry       Date:  2005-01-15       Impact factor: 13.382

3.  Functional consequences of PRODH missense mutations.

Authors:  Hans-Ulrich Bender; Shlomo Almashanu; Gary Steel; Chien-An Hu; Wei-Wen Lin; Alecia Willis; Ann Pulver; David Valle
Journal:  Am J Hum Genet       Date:  2005-01-20       Impact factor: 11.025

4.  Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.

Authors:  Jussi Hirvonen; Theo G M van Erp; Jukka Huttunen; Sargo Aalto; Kjell Någren; Matti Huttunen; Jouko Lönnqvist; Jaakko Kaprio; Jarmo Hietala; Tyrone D Cannon
Journal:  Arch Gen Psychiatry       Date:  2005-04

5.  Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype.

Authors:  Andreas Meyer-Lindenberg; Philip D Kohn; Bhaskar Kolachana; Shane Kippenhan; Aideen McInerney-Leo; Robert Nussbaum; Daniel R Weinberger; Karen Faith Berman
Journal:  Nat Neurosci       Date:  2005-04-10       Impact factor: 24.884

6.  Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement: an electrochemical study in rat.

Authors:  N R Richardson; A Gratton
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

7.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

Authors:  Y Okubo; T Suhara; K Suzuki; K Kobayashi; O Inoue; O Terasaki; Y Someya; T Sassa; Y Sudo; E Matsushima; M Iyo; Y Tateno; M Toru
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

8.  Hyperprolinemia is a risk factor for schizoaffective disorder.

Authors:  H Jacquet; C Demily; E Houy; B Hecketsweiler; J Bou; G Raux; J Lerond; G Allio; S Haouzir; A Tillaux; C Bellegou; G Fouldrin; P Delamillieure; J F Ménard; S Dollfus; T D'Amato; M Petit; F Thibaut; T Frébourg; D Campion
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

9.  A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.

Authors:  M B Knable; T M Hyde; A M Murray; M M Herman; J E Kleinman
Journal:  Biol Psychiatry       Date:  1996-12-15       Impact factor: 13.382

10.  Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

Authors:  E V Gurevich; Y Bordelon; R M Shapiro; S E Arnold; R E Gur; J N Joyce
Journal:  Arch Gen Psychiatry       Date:  1997-03
View more
  40 in total

1.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

Review 2.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 3.  [Genuine motor phenomena in schizophrenia : Neuronal correlates and pathomechanisms].

Authors:  D Hirjak; G Northoff; P A Thomann; K M Kubera; R C Wolf
Journal:  Nervenarzt       Date:  2018-01       Impact factor: 1.214

4.  Empathy, schizotypy, and visuospatial transformations.

Authors:  Katharine N Thakkar; Sohee Park
Journal:  Cogn Neuropsychiatry       Date:  2010-04-30       Impact factor: 1.871

Review 5.  Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.

Authors:  Jussi Hirvonen; Jarmo Hietala
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

6.  Association study between BDNF C-281A polymorphism and paranoid schizophrenia in Polish population.

Authors:  Renata Suchanek; Aleksander Owczarek; Jan Kowalski
Journal:  J Mol Neurosci       Date:  2011-06-28       Impact factor: 3.444

Review 7.  [Genuine motor phenomena in schizophrenic psychoses : Theoretical background and definition of context].

Authors:  D Hirjak; G Northoff; P A Thomann; K M Kubera; R C Wolf
Journal:  Nervenarzt       Date:  2018-01       Impact factor: 1.214

8.  Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Authors:  Ruth Salo; Catherine Fassbender; Ana-Maria Iosif; Stefan Ursu; Martin H Leamon; Cameron Carter
Journal:  Psychiatry Res       Date:  2013-07-26       Impact factor: 3.222

9.  Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat.

Authors:  Leora Yetnikoff; Rhett A Reichard; Zachary M Schwartz; Kenneth P Parsely; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2014-04-01       Impact factor: 3.215

Review 10.  Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia.

Authors:  Gerhard Gross; Karsten Wicke; Karla U Drescher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.